PRESTIGE BIOPHARMA LIMITED

Last Updated: 14 Nov 2025

PRESTIGE BIOPHARMA LIMITED is ACRA -registered entity that has been operating for 10 years 5 months in Singapore since its incorporation in 2015.

Officially, PRESTIGE BIOPHARMA LIMITED is registered as Public Company Limited By Shares with its address 21 BIOPOLIS ROAD, #04-24, NUCLEOS, Singapore 138567.

Country of registration	Singapore
Registration number	201528785G
Local SIC	72106: Research and experimental development on environment and clean technologies
Incorporation date	13 Jul 2015
Company age	10 years 5 months
Official entity type	Public Company Limited By Shares
No. of officers	42

Contact

Address:

21 BIOPOLIS ROAD, #04-24, NUCLEOS, Singapore 138567

Phone number:

Access Key Decision Makers

This is the legal entity page of PRESTIGE BIOPHARMA LIMITED. To access company info, company size, news , key makers’ emails, visit the profile pages above.

The largest company and people database for SEA & ANZ

Associated business (1)

PRESTIGE BIOPHARMA GROUP (PRESTIGE BIOPHARMA / PRESTIGE BIOLOGICS)
Singapore
View More
cdmo
vaccines
noveldrugs
biosimilars
antibody therapeutics
research and development
clinical trials
manufacturing
diagnostics
pancreaticecancer
pharmaceuticals
pancreaticcancerdrug
pauf
Pharmaceuticals
Manufacturing
Prestige Biopharma (PBP) is an innovative biopharmaceutical company specializing in the discovery and development of innovative biologics and biosimilars. PBP1510 (Ulenistamab) is the First-in-Class Pancreatic Cancer drug which is on the stage of 1/2a global clinical phase. Based on our innovative biomarker, PAUF, we are continuing the challenge for overcoming hard-to-treat diseases such as pancreatic cancer. We are developing biosimilars to contribute on the patient's drug accessibility. Over 12 biosimilars we have been developing since 2015. And also, we are expanding the application of PAUF biomarker to the diagnostics. To expand the effectiveness of pancreatic cancer treatment, we are developing the diagnostic device. The primary focus of current PBP’s R&D is oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis. In parallel with our efforts to enhance safety, efficacy, and affordability of existing antibody therapeutics, PBP thrives to search for new targets and candidates with a goal to free mankind from devastating diseases Established on core values cherishing life and fostering the spirit of philanthropy, Prestige BioPharma promises to grow everyday to make our dream come true.

This is the legal entity page of PRESTIGE BIOPHARMA LIMITED. To access company info, company size, news, key maker's emails, visit the profile pages above.

Financials

Auditor	NEXIA SINGAPORE PAC
Revenue	> 10m
Share Capital - Ordinary shares	USD 534,859,605

Last updated: 14 Nov 2025

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Discover More Companies

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

What is the address of PRESTIGE BIOPHARMA LIMITED?
Where is PRESTIGE BIOPHARMA LIMITED's headquarter?
What is PRESTIGE BIOPHARMA LIMITED's contact number?
What PRESTIGE BIOPHARMA LIMITED's spending power?
Does PRESTIGE BIOPHARMA LIMITED have a presence in the domain it operates in?